The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

被引:270
|
作者
Dutta, Noton K. [1 ]
Mazumdar, Kaushiki [2 ]
Gordy, James T. [3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA
[2] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA
关键词
coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); nucleocapsid protein; vaccine; SARS-CORONAVIRUS; GENOME SEQUENCE; NEUTRALIZATION; ANTIBODIES; VIRUS;
D O I
10.1128/JVI.00647-20
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Measuring DNA folding by the SARS-CoV-2 nucleocapsid protein
    Kim, Jake J.
    Choi, Youna N.
    Carter, Ashley R.
    [J]. BIOPHYSICAL JOURNAL, 2023, 122 (03) : 74A - 74A
  • [22] Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus
    Zheng, Xiaoqin
    Sun, Zeyu
    Yu, Liang
    Shi, Danrong
    Zhu, Miaojin
    Yao, Hangping
    Li, Lanjuan
    [J]. PATHOGENS, 2021, 10 (09):
  • [23] Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides
    Petrovskis, Ivars
    Skrastina, Dace
    Jansons, Juris
    Dislers, Andris
    Bogans, Janis
    Spunde, Karina
    Neprjakhina, Anastasija
    Zakova, Jelena
    Zajakina, Anna
    Sominskaya, Irina
    [J]. VACCINES, 2024, 12 (03)
  • [24] Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells
    Y. V. Khramtsov
    A. V. Ulasov
    T. N. Lupanova
    G. P. Georgiev
    A. S. Sobolev
    [J]. Doklady Biochemistry and Biophysics, 2023, 510 : 87 - 90
  • [25] Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells
    Khramtsov, Y. V.
    Ulasov, A. V.
    Lupanova, T. N.
    Georgiev, G. P.
    Sobolev, A. S.
    [J]. DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 510 (01) : 87 - 90
  • [26] Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
    Terry, James S.
    Anderson, Loran BR.
    Scherman, Michael S.
    McAlister, Carley E.
    Perera, Rushika
    Schountz, Tony
    Geiss, Brian J.
    [J]. VIROLOGY, 2021, 558 : 28 - 37
  • [27] Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets
    Oliveira, Sergio C.
    de Magalhaes, Mariana T. Q.
    Homan, E. Jane
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [28] Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection
    Li, Tao
    Wang, Li
    Wang, Huihui
    Li, Xuemei
    Zhang, Shubing
    Xu, Yuanhong
    Wei, Wei
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [29] Single-molecule spectroscopy of the SARS-CoV-2 nucleocapsid protein
    Cubuk, Jasmine
    Incicco, J. Jeremias
    Stuchell-Brereton, Melissa D.
    Hall, Kathleen B.
    Soranno, Andrea
    [J]. BIOPHYSICAL JOURNAL, 2024, 123 (03) : 71A - 71A
  • [30] Production and Characterization of a SARS-CoV-2 Nucleocapsid Protein Reference Material
    Stocks, Bradley B.
    Thibeault, Marie-Pier
    L'Abbe, Denis
    Stuible, Matthew
    Durocher, Yves
    Melanson, Jeremy E.
    [J]. ACS MEASUREMENT SCIENCE AU, 2022, 2 (06): : 620 - 628